G1 THERAPEUTICS INC. - COMMON STOCK

Initial Results from Phase 2 Mechanism of Action Trial in Early-Stage Triple Negative Breast Cancer Show that a Single Dose of Trilaciclib Favorably Alters the Tumor Microenvironment

07 12月 2022 17:04:19 条件 Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 12月 2022 22:41:26 条件 Nasdaq GlobeNewswire

G1 Therapeutics to Participate in the Virtual Evercore ISI HealthCONx Conference

23 11月 2022 09:30:26 条件 Nasdaq GlobeNewswire

G1 Therapeutics Announces Closing of Offering of Common Stock

22 11月 2022 15:01:04 条件 Nasdaq GlobeNewswire

G1 Therapeutics Announces Pricing of Offering of Common Stock

17 11月 2022 19:12:26 条件 Nasdaq GlobeNewswire

G1 Therapeutics Announces Proposed Public Offering of Common Stock

17 11月 2022 15:01:05 条件 Nasdaq GlobeNewswire

G1 Therapeutics Provides Third Quarter 2022 Financial Results and Operational Highlights

02 11月 2022 05:30:33 条件 Nasdaq GlobeNewswire

Initial Results from Phase 2 Trial Demonstrate Potential of Trilaciclib to Reduce Adverse Events Related to an Antibody Drug Conjugate (ADC)

02 11月 2022 05:28:23 条件 Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 11月 2022 16:40:30 条件 Nasdaq GlobeNewswire

G1 Therapeutics Announces Investigator Initiated Study of Trilaciclib and Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer

26 10月 2022 08:26:34 条件 Nasdaq GlobeNewswire

G1 Therapeutics to Release Third Quarter 2022 Financial Results and Provide Business Update on November 2, 2022

19 10月 2022 11:30:57 条件 Nasdaq GlobeNewswire

G1 Therapeutics Completes Enrollment in Global Multi-Center Phase 3 Clinical Trial of Trilaciclib in Patients with Metastatic Triple Negative Breast Cancer (TNBC)

10 10月 2022 05:30:06 条件 Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 10月 2022 16:00:53 条件 Nasdaq GlobeNewswire

G1 Therapeutics to Participate Virtually in the H.C. Wainwright 24th Annual Global Investment Conference

07 9月 2022 07:00:29 条件 Nasdaq GlobeNewswire

G1 Therapeutics to Host Virtual R&D Day on September 15, 2022

06 9月 2022 06:00:15 条件 Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 9月 2022 16:22:08 条件 Nasdaq GlobeNewswire

G1 Therapeutics Provides Second Quarter 2022 Financial Results and Operational Highlights

03 8月 2022 05:30:32 条件 Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 8月 2022 16:15:05 条件 Nasdaq GlobeNewswire

G1 Therapeutics Announces Addition of Norman E. Sharpless to Board of Directors

25 7月 2022 05:30:43 条件 Nasdaq GlobeNewswire

G1 Therapeutics to Release Second Quarter 2022 Financial Results and Provide Business Update on August 3, 2022

20 7月 2022 08:00:31 条件 Nasdaq GlobeNewswire